论文部分内容阅读
目的预测中央角膜厚度在高眼压症转归中的作用。方法将门诊用非接触眼压计检测的高眼压症患者做超声角膜厚度测量,中央角膜厚度大于及等于575μm的患者60例(120只眼)纳入本研究,不予降眼压治疗,追踪观察眼压、视乳头、视野变化。结果随访36～76个月,平均48个月。其中1例1只眼出现视野改变,发生率为0.83%(1/120)。结论角膜厚度是判断高眼压症是否发展为青光眼的最有力的预测因素.常规中央角膜厚度测量对高眼压症患者的合理处理是非常重要的。中央角膜偏厚且眼压低于28mmHg的高眼压症患者不需要抗青光眼治疗,仅需定期观察。
Objective To predict the role of central corneal thickness in the prognosis of ocular hypertension. Methods Ocular ocular thickness was measured in outpatients with ocular hypertension by non-contact tonometer. 60 patients (120 eyes) with central corneal thickness greater than or equal to 575 μm were included in this study. IOP observation, depending on the nipple, visual field changes. The results were followed up 36 to 76 months, an average of 48 months. One case of 1 eye visual field changes, the incidence was 0.83% (1/120). Conclusions Corneal thickness is the most powerful predictor of whether or not ocular hypertension develops into glaucoma, and routine central corneal thickness measurement is very important for the proper management of ocular hypertension. Patients with ocular hypertension who have a thicker central cornea and an intraocular pressure of less than 28 mmHg do not need anti-glaucoma treatment and only need regular observation.